UBCO researchers suggest stool transplants can battle serious infections

December 09, 2020

Could number two be number one when it comes to combating recurrent Clostridium difficile (CDI) infections?

Using genetic material analysis and machine learning, UBC researchers have pinpointed several key factors to ensure successful fecal microbiota transplants (FMT), which have proven successful in treating bacterial infections in the gut including illnesses like C. difficile, Crohn's Disease, Colitis and even obesity, explains lead author Negin Kazemian.

"This therapy is still in its infancy, but studies like ours are helping identify key contributors to its overall success," says Kazemian, a graduate student at UBC Okanagan's School of Engineering.

Kazemian and her supervisor, Assistant Professor Sepideh Pakpour, are investigating the internal dynamics of both donors and recipients to set out a formula for the effectiveness of the therapy.

C. difficile is one of the most frequently identified health care-associated infection in North America, she adds. Once a patient gets it, the illness often recurs, making a significant negative impact on a patient's gut microorganisms.

Kazemian explains that severely damaged gut ecosystems, like someone who has had C. difficile, are not self-renewing. Therefore, FMT can help by restoring damaged systems through the recreation of the original ecosystem, or the construction of an entirely new and alternative ecosystem.

"In our study, we showed that the success of gut ecological recovery through FMT is dependent on several factors, including the donor gut microbiome--the presence of specific bacteria--as well as the recipient's pre-FMT gut community structures and the absence of specific bacteria and fungi."

Some previous studies have pointed to the possibility of "super" donors, but these new findings indicate the relationship between donors and recipients is much more complex. Pakpour says the notion of the super-donor is oversimplified due to the observed short-term fluctuations. A recipient's microbiota may be just as important to consider when predicting treatment outcomes, especially in unbalanced conditions such as ulcerative colitis.

"Take, for example, blood transplants where we have a strong understanding of the four main blood groups or types, and how they interact with one another," says Pakpour. "With fecal transplants the research up to this point has not been as clear in what constitutes a good match or compatibility."

Working with data from the University of Alberta Hospital, Kazemian and Pakpour analyzed the gut composition and DNA from samples extracted before and after FMT.

According to Kazemian, their findings indicate that there isn't a "one stool fits all" approach to ensure transplant success.

"The data illustrates that the unique microorganisms in everyone's bodies respond differently over time, and this has profound implications on whether these transplants work well or not."

The researchers suggest that preparing donors and patients' gut ecosystems prior to transplant, maybe by using metabolites, would potentially sync their microbiota leading the way to a higher probability of transplant success.
-end-
The new research is published in Nature Research's Scientific Report.

University of British Columbia Okanagan campus

Related Microbiota Articles from Brightsurf:

Glyphosate may affect human gut microbiota
More than half of bacterial species in the core of the human gut microbiome are potentially sensitive to glyphosate, shows new research.

The gut microbiota forms a molecule that can contribute to diabetes progression
It is the bacterial changes in the gut that increase the levels of imidazole propionate, the molecule that makes the body's cells resistant to insulin in type 2 diabetes.

Link between Alzheimer's disease and gut microbiota is confirmed
In recent years, the scientific community has suspected that the gut microbiota plays a role in the development of the disease.

Multi-mucus barrier segregates colon microbiota from host tissue
Whole-colon imaging in mice has revealed a continuous colonic mucus system, which forms a protective barrier between potentially harmful gut microbiota and host tissue by encapsulating fecal pellets as they form and as they are eliminated from the colon.

Fecal transplantation can restore the gut microbiota of C-section babies
Birth by Cesarean section is detrimental to normal gut microbiota development.

Feeding C-section newborns their mother's poop may help build healthy microbiota
A paper published October 1, 2020 in the journal Cell suggests that newborns delivered by cesarean may benefit from drinking a small amount of their mother's feces dissolved in breast milk, because it provides them with beneficial bacteria they would otherwise be exposed to in vaginal birth.

Stronger bones thanks to heat and microbiota
Osteoporosis is characterised by a deterioration of the bones and an increased risk of fractures.

Gut microbiota not involved in the incidence of gestational diabetes mellitus
Consuming the combination of fish oil and probiotic food supplements modulate the composition of gut microbiota in overweight and obese pregnant women, reveals a new study conducted at the University of Turku, Finland.

Studies of gut microbiota and contractility help deal with chronic constipation
Chronic constipation (CC) remains a serious medical and social problem because the complexity of diagnosis, the lack of a single approach to treatment, and unsatisfactory treatment results.

Penis microbiota predicts if a man's female partner will develop bacterial vaginosis
Penile microbiome composition can vary; however, the presence of some bacterial vaginosis-related bacteria correlates with bacterial vaginosis onset in their female partners.

Read More: Microbiota News and Microbiota Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.